Dividend compounder review
QGEN
Qiagen NV · NYSE · US
Healthcare · Diagnostics & Research
Score68.95/100
Confidence100.00/100
DecisionReject
RatingAcceptable, Needs Review
Quality breakdown
Dividend Reliability
9.9 / 25
Payment history, cuts, growth, and regularity.
Dividend Sustainability
20.0 / 20
Payout, free cash flow, dividend cover, and debt.
Business Quality
22.5 / 25
Scale, cash generation, growth, margins, and returns.
Valuation Discipline
15.0 / 15
Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend
1.5 / 15
Trend line, long return history, and drawdown control.
Dividend and business context
Dividend Years4
Dividend Yield0.94%
Payout Ratio13.4%
Dividend Cut 5YYes
Net Income$424.9M
Free Cash Flow$447.2M
FCF Covers DividendYes
Debt / Equity0.50
P/E18.9
Revenue Growth 5Y2.2%
Net Margin19.2%
ROE11.9%
Price vs Trend-14.4%
3Y Return-17.8%
5Y Return-23.3%
CurrencyUSD
Review flags
Dividend history is short: 4 completed years.
Dividend cut or material annual decrease detected in the last five completed years.
Activity record
Dividend cut or material annual decrease detected in the last five completed years.
Payment changed from 1.358 to 0.25.
Recorded dividend payment for Qiagen NV.
Payment changed from 1.154 to 1.358.
Recorded dividend payment for Qiagen NV.
Payment changed from 0.02979 to 1.154.
Recorded dividend payment for Qiagen NV.
Payment changed from 0.002207 to 0.02979.
Recorded dividend payment for Qiagen NV.
Recorded dividend payment for Qiagen NV.